Tem8-Peptide und Impfstoffe damit

Patent europeic · EP2508601 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2508601
Numer da la dumonda
EP12166766
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
10-04-2008
Publitgà
10-10-2012
Concedì
05-11-2014
Stritgà
30-04-2015
Motiv
Taxa annuala betg pajada
Classas IPC
C12N 15/00 (2006.01)
A61K 39/00 (2006.01)
A61P 35/00 (2006.01)
C07K 7/06 (2006.01)
C07K 14/705 (2006.01)
C12N 5/00 (2006.01)
Prioritad
US 911194 P 11.04.2007
Derivà da
EP08738544
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 18-11-2015

    Stritgà, taxa betg pajada

    Published in Swissreg on 18.11.2015

  2. 25-11-2014

    Represchentant inscrit

    Representative
    Vossius & Partner, Nadelberg 3, 4051 Basel

    Published in Swissreg on 25.11.2014

  3. 05-11-2014

    Concedì

    Published in Swissreg on 05.11.2014

Partidas

Possessur

OncoTherapy Science, Inc.

Oncotherapy Science, Inc.

2-1, Sakado 3-chome Takatsu-ku, Kawasaki-shi Kanagawa 213-0012, JP

Represchentant

Vossius & Partner

Nadelberg 3, 4051 Basel

Inventur

Tsunoda, Takuya

Kanagawa, 213-0012, JP

Osawa, Ryuji

Kanagawa, 213-0012, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.